Sinovac Biotech (北京科兴生物制品有限公司) announced a second large H1N1 flu vaccine order from China’s national government. The new order is for an additional 3 million doses, which follows the original 3.3 million dose order of early September. Sinovac expects to deliver 4.5 million doses of its PANFLU.1 flu vaccine to the government by the end of October. More details...

Stock Symbol: (NYSE: SVA)